Video: Letting Nature Lead – with John Maher - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Video: Letting Nature Lead – with John Maher

  • November 16, 2026

  • 1 min

Share

Objective:

The video interview explores John Maher’s path into immunology, contributions to CAR T-cell development, and the thinking behind his current research.

Approach:
  • Career: Maher is a clinical immunologist, Scientific Founder and Chief Scientific Officer of Leucid Bio, and leads the CAR Mechanics research group at King’s College London.
  • Research background: His work spans more than two decades, focusing particularly on CAR T-cell treatments for solid tumors.
  • CAR technology: At Memorial Sloan Kettering Cancer Center, Maher helped develop second-generation CAR technology incorporating the CD28 costimulatory molecule.
Key Findings:
  • The CD28-containing second-generation CAR approach subsequently achieved clinical success in blood cancers.
  • Maher’s career combines academic research, clinical practice, and cell-therapy development.
Interpretation:

The interview presents Maher’s career and research perspective on CAR T-cell immunotherapy.

Limitations:
  • The supplied context does not provide interview details, study methods, or additional findings.

Original Source(s)

Related Content